- Home
- TERN vs BTO Comparison
TERN vs BTO Comparison
Compare TERN & BTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- BTO
- Stock Information
- Founded
- TERN 2017
- BTO 1994
- Country
- TERN United States
- BTO United States
- Employees
- TERN N/A
- BTO N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- BTO Investment Managers
- Sector
- TERN Health Care
- BTO Finance
- Exchange
- TERN Nasdaq
- BTO Nasdaq
- Market Cap
- TERN 634.5M
- BTO 747.9M
- IPO Year
- TERN 2021
- BTO N/A
- Fundamental
- Price
- TERN $7.30
- BTO $35.48
- Analyst Decision
- TERN Buy
- BTO
- Analyst Count
- TERN 6
- BTO 0
- Target Price
- TERN $13.99
- BTO N/A
- AVG Volume (30 Days)
- TERN 1.1M
- BTO 54.2K
- Earning Date
- TERN 11-11-2025
- BTO 01-01-0001
- Dividend Yield
- TERN N/A
- BTO 9.13%
- EPS Growth
- TERN N/A
- BTO N/A
- EPS
- TERN N/A
- BTO N/A
- Revenue
- TERN N/A
- BTO N/A
- Revenue This Year
- TERN N/A
- BTO N/A
- Revenue Next Year
- TERN N/A
- BTO N/A
- P/E Ratio
- TERN N/A
- BTO N/A
- Revenue Growth
- TERN N/A
- BTO N/A
- 52 Week Low
- TERN $1.87
- BTO $22.95
- 52 Week High
- TERN $10.70
- BTO $32.81
- Technical
- Relative Strength Index (RSI)
- TERN 52.85
- BTO 38.15
- Support Level
- TERN N/A
- BTO $37.41
- Resistance Level
- TERN $7.67
- BTO $37.96
- Average True Range (ATR)
- TERN 0.41
- BTO 0.51
- MACD
- TERN -0.32
- BTO -0.25
- Stochastic Oscillator
- TERN 93.83
- BTO 4.91
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About BTO John Hancock Financial Opportunities Fund
John Hancock Financial Opportunities Fund is the United States based closed-end, diversified management investment company. Its investment objective is to provide a high level of total return consisting of long-term capital appreciation and current income. The company invests in banks, capital markets, Insurance, Mortage Real Estate Investment trust, Health Care REITs, Diversified REITs, Office REITs.